Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Single-Cell Analysis | 9 | 2024 | 358 | 2.700 |
Why?
|
| RNA | 4 | 2024 | 607 | 2.190 |
Why?
|
| Gene Expression Profiling | 8 | 2024 | 1923 | 1.890 |
Why?
|
| Sequence Analysis, RNA | 6 | 2024 | 426 | 1.880 |
Why?
|
| Transcriptome | 7 | 2024 | 1138 | 1.020 |
Why?
|
| Alzheimer Disease | 2 | 2023 | 880 | 0.880 |
Why?
|
| Cellular Senescence | 2 | 2024 | 201 | 0.830 |
Why?
|
| Transcription Factors | 4 | 2024 | 2738 | 0.820 |
Why?
|
| Cell Cycle | 2 | 2024 | 628 | 0.770 |
Why?
|
| Connectome | 1 | 2024 | 118 | 0.750 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2021 | 167 | 0.620 |
Why?
|
| Synapses | 1 | 2023 | 469 | 0.610 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2012 | 72 | 0.490 |
Why?
|
| Autism Spectrum Disorder | 1 | 2021 | 428 | 0.490 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 738 | 0.460 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2017 | 964 | 0.440 |
Why?
|
| Lysogeny | 2 | 2010 | 11 | 0.440 |
Why?
|
| Macrophages | 2 | 2019 | 711 | 0.440 |
Why?
|
| Glioblastoma | 1 | 2017 | 375 | 0.420 |
Why?
|
| Synaptosomes | 2 | 2024 | 31 | 0.420 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 2178 | 0.390 |
Why?
|
| DNA, Neoplasm | 1 | 2012 | 320 | 0.370 |
Why?
|
| Hair Cells, Auditory | 2 | 2024 | 65 | 0.360 |
Why?
|
| Point Mutation | 1 | 2012 | 362 | 0.360 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2010 | 39 | 0.350 |
Why?
|
| Cancer-Associated Fibroblasts | 2 | 2021 | 21 | 0.340 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2010 | 173 | 0.320 |
Why?
|
| Genomic Instability | 1 | 2010 | 248 | 0.310 |
Why?
|
| Tumor Microenvironment | 5 | 2021 | 698 | 0.300 |
Why?
|
| Genomics | 1 | 2017 | 1681 | 0.290 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 1034 | 0.270 |
Why?
|
| Neovascularization, Pathologic | 2 | 2020 | 263 | 0.270 |
Why?
|
| Colorectal Neoplasms | 1 | 2012 | 652 | 0.250 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2019 | 406 | 0.250 |
Why?
|
| Repressor Proteins | 1 | 2010 | 874 | 0.240 |
Why?
|
| Cell Line, Tumor | 5 | 2021 | 3798 | 0.230 |
Why?
|
| Genome, Human | 3 | 2021 | 1351 | 0.230 |
Why?
|
| Gene Expression Regulation | 3 | 2024 | 2669 | 0.210 |
Why?
|
| Kinetics | 2 | 2024 | 1357 | 0.210 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 2947 | 0.210 |
Why?
|
| Deafness | 1 | 2024 | 87 | 0.210 |
Why?
|
| RNA Splicing | 1 | 2024 | 252 | 0.200 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2021 | 25 | 0.180 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2021 | 27 | 0.180 |
Why?
|
| Animals | 10 | 2024 | 36557 | 0.180 |
Why?
|
| Golgi Apparatus | 1 | 2021 | 97 | 0.180 |
Why?
|
| Escherichia coli | 3 | 2011 | 1027 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2021 | 152 | 0.170 |
Why?
|
| Bacteriophage lambda | 2 | 2010 | 28 | 0.170 |
Why?
|
| Gene Amplification | 1 | 2021 | 247 | 0.170 |
Why?
|
| Humans | 15 | 2024 | 134156 | 0.170 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2021 | 124 | 0.170 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 178 | 0.160 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2020 | 161 | 0.160 |
Why?
|
| Tamoxifen | 1 | 2021 | 377 | 0.160 |
Why?
|
| Saccule and Utricle | 1 | 2019 | 12 | 0.160 |
Why?
|
| Mice | 6 | 2023 | 19055 | 0.160 |
Why?
|
| Reverse Transcription | 1 | 2019 | 5 | 0.150 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 251 | 0.150 |
Why?
|
| Myeloid Cells | 1 | 2019 | 123 | 0.150 |
Why?
|
| Gene Library | 1 | 2019 | 225 | 0.140 |
Why?
|
| Carcinogenesis | 1 | 2021 | 364 | 0.140 |
Why?
|
| DNA, Complementary | 1 | 2019 | 472 | 0.140 |
Why?
|
| Gene Ontology | 1 | 2017 | 55 | 0.140 |
Why?
|
| DNA Damage | 1 | 2021 | 547 | 0.140 |
Why?
|
| Macrophage Activation | 1 | 2017 | 68 | 0.140 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2021 | 645 | 0.140 |
Why?
|
| Morphogenesis | 1 | 2018 | 215 | 0.140 |
Why?
|
| Pancreas | 1 | 2018 | 232 | 0.140 |
Why?
|
| Aurora Kinases | 1 | 2017 | 28 | 0.140 |
Why?
|
| Regeneration | 1 | 2019 | 231 | 0.130 |
Why?
|
| Benzamides | 1 | 2017 | 125 | 0.130 |
Why?
|
| Kidney Neoplasms | 1 | 2021 | 462 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 2 | 2012 | 1837 | 0.130 |
Why?
|
| Epithelial Cells | 1 | 2021 | 937 | 0.130 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2019 | 277 | 0.120 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 719 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 1 | 2017 | 228 | 0.120 |
Why?
|
| Bone and Bones | 1 | 2017 | 311 | 0.110 |
Why?
|
| Pyrazoles | 1 | 2017 | 331 | 0.110 |
Why?
|
| HEK293 Cells | 1 | 2017 | 825 | 0.110 |
Why?
|
| Immunotherapy | 1 | 2019 | 752 | 0.110 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2017 | 507 | 0.110 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 773 | 0.110 |
Why?
|
| Neoplasms | 2 | 2020 | 3038 | 0.100 |
Why?
|
| Mutation Rate | 1 | 2012 | 72 | 0.100 |
Why?
|
| Meiosis | 1 | 2012 | 117 | 0.100 |
Why?
|
| Computational Biology | 1 | 2017 | 890 | 0.100 |
Why?
|
| Bone Neoplasms | 1 | 2017 | 447 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 610 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 1167 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 3857 | 0.090 |
Why?
|
| Brain | 1 | 2024 | 3224 | 0.090 |
Why?
|
| Cell Line | 1 | 2017 | 2864 | 0.090 |
Why?
|
| Cochlea | 2 | 2024 | 90 | 0.090 |
Why?
|
| Recombination, Genetic | 1 | 2012 | 451 | 0.090 |
Why?
|
| Organisms, Genetically Modified | 1 | 2010 | 11 | 0.090 |
Why?
|
| Time | 1 | 2011 | 101 | 0.090 |
Why?
|
| Spermatozoa | 1 | 2012 | 251 | 0.090 |
Why?
|
| Genes, Viral | 1 | 2010 | 186 | 0.080 |
Why?
|
| Bacteriolysis | 1 | 2010 | 8 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 1787 | 0.080 |
Why?
|
| Genome, Bacterial | 1 | 2010 | 212 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 1853 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 1761 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 1071 | 0.060 |
Why?
|
| Models, Biological | 1 | 2010 | 1539 | 0.060 |
Why?
|
| Epithelium | 1 | 2024 | 366 | 0.050 |
Why?
|
| Mammals | 1 | 2024 | 282 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 2137 | 0.050 |
Why?
|
| 1-Phosphatidylinositol 4-Kinase | 1 | 2021 | 10 | 0.050 |
Why?
|
| Alpha-Globulins | 1 | 2021 | 11 | 0.050 |
Why?
|
| Discoidin Domain Receptor 2 | 1 | 2021 | 6 | 0.050 |
Why?
|
| RNA, Neoplasm | 1 | 2021 | 146 | 0.040 |
Why?
|
| Cell Communication | 1 | 2021 | 188 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2021 | 650 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2021 | 249 | 0.040 |
Why?
|
| Granulocytes | 1 | 2019 | 71 | 0.040 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2019 | 51 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 4879 | 0.040 |
Why?
|
| Stromal Cells | 1 | 2020 | 313 | 0.040 |
Why?
|
| Cell Death | 1 | 2019 | 252 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2021 | 488 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2021 | 915 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2018 | 153 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2020 | 370 | 0.040 |
Why?
|
| Transduction, Genetic | 1 | 2019 | 296 | 0.040 |
Why?
|
| Fibrosis | 1 | 2020 | 463 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2021 | 4934 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 2018 | 485 | 0.030 |
Why?
|
| Pericytes | 1 | 2017 | 25 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 4808 | 0.030 |
Why?
|
| Cell Movement | 1 | 2021 | 920 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2020 | 417 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2017 | 68 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2017 | 103 | 0.030 |
Why?
|
| Biphenyl Compounds | 1 | 2017 | 63 | 0.030 |
Why?
|
| Neutrophils | 1 | 2019 | 402 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 2017 | 77 | 0.030 |
Why?
|
| Morpholines | 1 | 2017 | 64 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2017 | 110 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2017 | 159 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 145 | 0.030 |
Why?
|
| Pyridones | 1 | 2017 | 129 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2018 | 837 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2017 | 241 | 0.030 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2017 | 246 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 2539 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2017 | 538 | 0.030 |
Why?
|
| Female | 5 | 2019 | 71928 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 1089 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2021 | 951 | 0.030 |
Why?
|
| Cytokines | 1 | 2020 | 1401 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 1012 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2018 | 1051 | 0.030 |
Why?
|
| Disease Progression | 1 | 2020 | 2266 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2021 | 2563 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2017 | 544 | 0.030 |
Why?
|
| Stem Cells | 1 | 2018 | 754 | 0.030 |
Why?
|
| Transcription Initiation Site | 1 | 2012 | 34 | 0.030 |
Why?
|
| Crossing Over, Genetic | 1 | 2012 | 54 | 0.020 |
Why?
|
| Chromosome Segregation | 1 | 2012 | 69 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2012 | 137 | 0.020 |
Why?
|
| Gene Expression | 1 | 2017 | 1621 | 0.020 |
Why?
|
| Aneuploidy | 1 | 2012 | 146 | 0.020 |
Why?
|
| Male | 4 | 2021 | 66127 | 0.020 |
Why?
|
| Haplotypes | 1 | 2012 | 560 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2018 | 2045 | 0.020 |
Why?
|
| Heterozygote | 1 | 2012 | 728 | 0.020 |
Why?
|
| Bacteriological Techniques | 1 | 2010 | 90 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2011 | 458 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2011 | 793 | 0.020 |
Why?
|
| Prognosis | 1 | 2017 | 5086 | 0.020 |
Why?
|
| Pregnancy | 1 | 2018 | 7570 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2011 | 2915 | 0.010 |
Why?
|
| Adult | 1 | 2024 | 31945 | 0.010 |
Why?
|
| Middle Aged | 1 | 2012 | 29399 | 0.010 |
Why?
|